The regulatory activity of ERα in the Luminal A (ERα+, PR+, HER2-) subtype of breast cancer is one of the most studied gene regulatory mechanisms, and this type of breast cancer cells are therefore an excellent estrogen-responsive cell model to use for comparison of the two homologues. Here, ERBB2 is linked to breast carcinoma.